As mandated by the U.S. Food and Drug Administration (FDA), American Medical Systems (AMS) has started its transvaginal mesh study by enrolling its first participant. The transvaginal mesh manufacturer announced the enrollment in a press release published by the Wall Street Journal.
According to the press release, the AMS study will take place over a period of five years, with two years designated as an enrollment period, and the remaining three years allotted for tracking patient health. The study is to look at the AMS transvaginal mesh product, Elevate (TM) Anterior and Apical Prolapse Repair System.
Though news of the AMS transvaginal mesh study is a welcome announcement, such an in-depth examination of the health effects of transvaginal mesh for the treatment of pelvic organ prolapse (POP) would have best been conducted prior to releasing these types of products onto the market.
Carey Danis & Lowe Represents Victims
A law firm headquartered in St. Louis, Carey Danis & Lowe is dedicated to providing their expert legal assistance to victims of transvaginal mesh. Our team of defective medical device and personal injury lawyers understand the pain and suffering that individuals and families endure in the wake of injuries from a defective product. If you or someone you love has been injured by transvaginal mesh, work with a team of lawyers that are committed to your case.
Explore your legal options and compensation eligibility with a Carey Danis & Lowe lawyer today. Our initial consultations are free.